CDS Information : AO090120000461

Display	1000bp 10000bp 100000bp Clone

Aspergillus oryzae RIB40 (= NBRC 100959) chromosome5	Legend Jump
Contig Overview  Genome Proteome  Clone

Center position	SC111SC124SC113	change
ID		change
Gene name		change

Organism	Aspergillus oryzae RIB40 (= NBRC 100959)
Replicon	chromosome5
Contig	SC113
Start / Stop / Direction	1,233,940 / 1,235,462 / +
Location	join(1233940..1234774, 1234855..1235462)
Type	CDS
Length	1,443 bp (480 aa)
Intron	1234775..1234854

Product	glycosyltransferase
Gene name
Functional category	Cellular processes and signaling - [M] Cell wall/membrane/envelope biogenesis
EC number
Note
KEGG pathway
Sequence feature
References

BLASTP Database:UniProtKB:2010_04 show BLAST table	1 E=0 Q2U5Y1_ASPOR Glycosyltransferase Alignment 2 E=0 B8NLX9_ASPFN Alpha-1,2-mannosyltransferase (Alg2), putative Alignment 3 E=0 Q0CJE4_ASPTN Alpha-1,3-mannosyltransferase alg-2 Alignment 4 E=0 A1DDK9_NEOFI Alpha-1,2-mannosyltransferase (Alg2), putative Alignment 5 E=0 Q4WVT1_ASPFU Alpha-1,2-mannosyltransferase (Alg2), putative Alignment
HAMAP	No significant hit
InterPro	No significant hit
SignalP	No significant hit
TMHMM	Transmembrane 1
SOSUI	Transmembrane 1

size of protein	480 amino acids
molecular mass	53,619.05 Da
pI	7.7
aa composition	Ala Val Leu Ile Phe Trp Pro Met Gly Ser 8.8 (42aa) 8.5 (41aa) 11.7 (56aa) 5.6 (27aa) 4.8 (23aa) 1 (5aa) 3.3 (16aa) 2.7 (13aa) 7.1 (34aa) 5.8 (28aa) Thr Cys Asn Gln Tyr Lys His Arg Asp Glu 5 (24aa) 0.8 (4aa) 2.3 (11aa) 2.5 (12aa) 2.1 (10aa) 5.2 (25aa) 2.5 (12aa) 7.5 (36aa) 6 (29aa) 6.7 (32aa)

>AO090120000461 glycosyltransferase
ATGCCGGGCCTCAAACGCTCCAATGTGATCATCATCCACCCCGATCTGGGCATCGGCGGT
GCCGAGCGTCTTATCATCGACGTGGCGCTTGCGCTCCAAAACCGCGGCCACAAAGTAACG
ATCTACACCTCGCACCGCGACAAATCACACTGTTTCGAAGAAGCGCGCGATGGTACCCTC
GACGTTAAAGTGCGGGGCAACACGATATTCCCCGCGCACGTATTCCGACGATTCCATGTC
CTGATGGCGATCTTAAGACAGTTACATCTCACCATTTCAGTCCTGGGAGAGACATCTCGT
ACTTCCGATACGAACGAGAAAAGCAAAGAGAGCGAGGTATTAGAAGATGACATCTTCATC
GTCGACCAAGTCCCCGCCTGCGTACCCTTTCTAAAGACGTTTGCGCGCCAACGACAGCGG
ATCCTCTTCTATTGTCACTTCCCGGACCAGTTACTTGCGTTTCGGGGCGAGGCCGGGTCG
CTCTTGAGTTTTGTGAAGACTCTTTATCGGTACCCGTTTGATTGGTTTGAGGGGTGGGCT
ATGAGTGCTTCTGATAAGGTTGTTGCGAATTCGAGGTTTACGAGGGGTGTTGTGAAGGAG
GTTTTTGGGGGTGAGAAGCTTGGCGATGTTAGTGTTGTTTATCCGTGTGTTGATACGGAG
GCTGCGGCTTTGAGGGATCCGGTGGTTGTGAAGGATGGGGAGACGTTGTGGGGTGGGAAG
AAGATTCTTTTGAGTATTAATCGGTTTGAGAGGAAGAAGGATATGGCGCTTGCTATTCGG
GCGTATCATGGGTTGGGGGCGGAGAAGAGGAGAGGGACTAGGTTGGTTATTGCTGGTGGT
TATGATAACCGGGTCCAGGAGAATGTGCAATATCATCGGGAACTGGACGAGCTTGCTACT
AGTCTGGGGTTGCAGACTGCTACGTCTAAGACGGTTATCTCGGCATTGTCTGTTCCGGAT
TCCATTGATGTGTTGTTTTTGTTGTCCGTGCCCTCTGCGTTCCGAGATATGCTACTCGAG
CATGCGAAATTGCTTCTTTACACGCCTATCAATGAGCACTTTGGCATTGTGCCTGTCGAG
GCGATGCGCGCTGGAATCCCCGTCCTGGCGTCGAATACCGGCGGCCCGTTGGAGACAATC
GTCGAGGGCGAAACGGGGTGGCTCCGCAACGCGAAGAAAGACGCCGACTGGACGGCGGTC
ATGGATAAGGTGCTCTACGGAATGGACCAGAAGGAGTTCGACAGGATGTCCATCGCCGCG
AAAGAGCGAGTGGAGCGGGAATTCTCCCTAACGGCCATGGGTGACCGACTGGAGGCGGAG
ATCTCGGACATGCTCGCGCGCGAGAGACGTCCGTTCGCCGGACTCCAGCAGATCCTCGTC
CTTTTGGCCCTGTCCGGAGTCATGCTCTCACTGCTTGCTGCTTTTGCCCTGAAGATGATC
TGA


>AO090120000461 glycosyltransferase
MPGLKRSNVIIIHPDLGIGGAERLIIDVALALQNRGHKVTIYTSHRDKSHCFEEARDGTL
DVKVRGNTIFPAHVFRRFHVLMAILRQLHLTISVLGETSRTSDTNEKSKESEVLEDDIFI
VDQVPACVPFLKTFARQRQRILFYCHFPDQLLAFRGEAGSLLSFVKTLYRYPFDWFEGWA
MSASDKVVANSRFTRGVVKEVFGGEKLGDVSVVYPCVDTEAAALRDPVVVKDGETLWGGK
KILLSINRFERKKDMALAIRAYHGLGAEKRRGTRLVIAGGYDNRVQENVQYHRELDELAT
SLGLQTATSKTVISALSVPDSIDVLFLLSVPSAFRDMLLEHAKLLLYTPINEHFGIVPVE
AMRAGIPVLASNTGGPLETIVEGETGWLRNAKKDADWTAVMDKVLYGMDQKEFDRMSIAA
KERVEREFSLTAMGDRLEAEISDMLARERRPFAGLQQILVLLALSGVMLSLLAAFALKMI


>AO090120000461 with intron
ATGCCGGGCCTCAAACGCTCCAATGTGATCATCATCCACCCCGATCTGGGCATCGGCGGT
GCCGAGCGTCTTATCATCGACGTGGCGCTTGCGCTCCAAAACCGCGGCCACAAAGTAACG
ATCTACACCTCGCACCGCGACAAATCACACTGTTTCGAAGAAGCGCGCGATGGTACCCTC
GACGTTAAAGTGCGGGGCAACACGATATTCCCCGCGCACGTATTCCGACGATTCCATGTC
CTGATGGCGATCTTAAGACAGTTACATCTCACCATTTCAGTCCTGGGAGAGACATCTCGT
ACTTCCGATACGAACGAGAAAAGCAAAGAGAGCGAGGTATTAGAAGATGACATCTTCATC
GTCGACCAAGTCCCCGCCTGCGTACCCTTTCTAAAGACGTTTGCGCGCCAACGACAGCGG
ATCCTCTTCTATTGTCACTTCCCGGACCAGTTACTTGCGTTTCGGGGCGAGGCCGGGTCG
CTCTTGAGTTTTGTGAAGACTCTTTATCGGTACCCGTTTGATTGGTTTGAGGGGTGGGCT
ATGAGTGCTTCTGATAAGGTTGTTGCGAATTCGAGGTTTACGAGGGGTGTTGTGAAGGAG
GTTTTTGGGGGTGAGAAGCTTGGCGATGTTAGTGTTGTTTATCCGTGTGTTGATACGGAG
GCTGCGGCTTTGAGGGATCCGGTGGTTGTGAAGGATGGGGAGACGTTGTGGGGTGGGAAG
AAGATTCTTTTGAGTATTAATCGGTTTGAGAGGAAGAAGGATATGGCGCTTGCTATTCGG
GCGTATCATGGGTTGGGGGCGGAGAAGAGGAGAGGGACTAGGTTGGTTATTGCTGGTATG
TCTTTGTTTTTGTCCTCTTCCTTTTGTTTTTCTTGATGTTGGGTGTGATGTGTTTGGCTG
ACGATGGTGCTATAGGTGGTTATGATAACCGGGTCCAGGAGAATGTGCAATATCATCGGG
AACTGGACGAGCTTGCTACTAGTCTGGGGTTGCAGACTGCTACGTCTAAGACGGTTATCT
CGGCATTGTCTGTTCCGGATTCCATTGATGTGTTGTTTTTGTTGTCCGTGCCCTCTGCGT
TCCGAGATATGCTACTCGAGCATGCGAAATTGCTTCTTTACACGCCTATCAATGAGCACT
TTGGCATTGTGCCTGTCGAGGCGATGCGCGCTGGAATCCCCGTCCTGGCGTCGAATACCG
GCGGCCCGTTGGAGACAATCGTCGAGGGCGAAACGGGGTGGCTCCGCAACGCGAAGAAAG
ACGCCGACTGGACGGCGGTCATGGATAAGGTGCTCTACGGAATGGACCAGAAGGAGTTCG
ACAGGATGTCCATCGCCGCGAAAGAGCGAGTGGAGCGGGAATTCTCCCTAACGGCCATGG
GTGACCGACTGGAGGCGGAGATCTCGGACATGCTCGCGCGCGAGAGACGTCCGTTCGCCG
GACTCCAGCAGATCCTCGTCCTTTTGGCCCTGTCCGGAGTCATGCTCTCACTGCTTGCTG
CTTTTGCCCTGAAGATGATCTGA

NBRC No.	clone name	start	stop	length(bp)
G07-113-126	B020E10	1,142,013	1,248,739	106,727
G07-113-127	B002A03	1,154,848	1,282,826	127,979
G07-113-128	B018B11	1,155,832	1,344,273	188,442
G07-113-129	B030F05	1,166,684	1,342,629	175,946
G07-113-131	B073A07	1,185,157	1,260,141	74,985
G07-113-132	B096G08	1,185,194	1,248,745	63,552
G07-113-133	B025B11	1,189,869	1,271,797	81,929
G07-113-134	B006A08	1,191,591	1,248,744	57,154
G07-113-135	B084C09	1,230,266	1,282,827	52,562

We have been distributing copies of the microbial genomic DNA clones constructed during the course of each of the genomic DNA sequencing projects.
You can find more detailed information at http://www.nbrc.nite.go.jp/e/mdna-e.html.